CELEX: 62014TN0048
Language: en
Date: 2014-01-21 00:00:00
Title: Case T-48/14: Action brought on 21 January 2014 — Pfizer v Commission and EMA

15.3.2014   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 78/15
            
         Action brought on 21 January 2014 — Pfizer v Commission and EMA
   (Case T-48/14)
   2014/C 78/30
   Language of the case: English
   
      Parties
   
   
      Applicant: Pfizer Ltd (Sandwich, United Kingdom) (represented by: K. Bacon and M. Schaefer, Barristers, I. Dodds-Smith, C. Stothers and J. Mulryne, Solicitors)
   
      Defendants: European Commission and European Medicines Agency
   
      Form of order sought
   
   The applicant claims that the Court should:
   
               —
            
            
               Annul the decision of the Commission and of EMA contained in the letters of 11 November 2013 and of 15 November 2013 not to issue the compliance statement; and
            
         
               —
            
            
               Order the Commission and EMA to bear the costs of the application.
            
         
      Pleas in law and main arguments
   
   In support of the action, the applicant relies on one plea in law, alleging that in contending that the compliance statement, for the applicant’s marketing authorisation of medicinal product Vfend, cannot be issued until the studies set out in the paediatric investigation plan (‘PIP’) have been assessed for the purposes of the new prophylaxis indication, the EMA has misinterpreted Article 28(3) of the Paediatric Regulation (1).
   
      (1)  Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (OJ L 378, p.1).